Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer
2024 · Molecular Cancer · 36 citations
https://doi.org/10.1186/s12943-024-01945-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
104
Citations
5
h-index
4
i10-index
Shan Peng is an academic researcher from Nanjing Drum Tower Hospital. The author has contributed to research in topics: Prostate Cancer Diagnosis and Treatment & Prostate Cancer Treatment and Research & Urologic and reproductive health conditions. The author has an h-index of 5, co-authored 12 publications.
ORCID: 0000-0002-4432-6008https://doi.org/10.1186/s12943-024-01945-9
https://doi.org/10.1186/s13046-025-03610-5
Click to start Chat